Middle East and Africa Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication (Quick Relief Medications and Long-Term Control Medications), Route of Administration (Inhaled, Prefilled Syringe/Vials, and Others), and Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies)
The Middle East and Africa asthma drugs market is expected to reach US$ 2,041.34 million by 2028 from US$ 1,568.27 million in 2021; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028.
The growth of the market is attributed to the rising prevalence of asthma and the increasing research activities and product innovations. However, the unmet medical needs hamper the market growth.
The treatment and management therapies for asthma have continued to develop with various drugs in the pipeline. Tezepelumab is a recently FDA-approved injection as an add-on maintenance treatment to improve severe asthma symptoms and the patient’s current asthma medicines. The drug targets and blocks thymic stromal lymphopoietin (TSLP), a key epithelial cytokine (cell-signaling proteins). Similarly, Masitinib, developed by AB Science, is an orally administered tyrosine kinase inhibitor that targets mast cells through inhibition of tyrosine kinases c-Kit, LYN, and FYN; it has recently been granted authorization by the French Medicine Agency to initiate a Phase III study to evaluate the drug in patients with Primary Progressive Multiple Sclerosis (PPMS) or non-active Secondary Progressive Multiple Sclerosis (nSPMS). Astegolimab is another promising monoclonal antibody showing promising efficacy in reducing asthma exacerbation rates. The emphasis on precision medicine for asthma control through the development of new asthma guidelines is also expected to create a positive change toward asthma drugs and individualized care.
In 2020, the FDA approved the triple therapy of fluticasone furoate, umeclidinium, and vilanterol (Trelegy Ellipta, GSK) for the treatment of asthma in patients aged 18 years and above. The approval was based on the CAPTAIN study (Clinical study of Asthma Patients receiving Triple therapy through A single INhaler), which showed significant improvements in lung function after using the triple therapy compared to fluticasone furoate and vilanterol in a single daily dose and an easy-to-use inhaler.
Various other research and clinical studies point toward the growth of the asthma drugs market with drug combinations, novel drugs, and other modes of drug delivery under research. These developments have created several drugs that resulted in a positive change, and with the ongoing research landscape, further drug discovery and development are expected in the coming years.
Middle East and Africa Asthma Drugs Market Revenue and Forecast to 2028 (US$ Mn)
Get more information on this report :
Middle East and Africa Asthma Drugs Market Segmentation
The Middle East and Africa asthma drugs market, by medication, is segmented into quick relief medications and long-term control medications. Based on route of administration, the market is segmented into inhaled, prefilled syringe/vials, and others. Based on distribution channel, the Asia Pacific asthma drugs market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. By country, the market is segmented into the Saudi Arabia, South Africa, UAE and Rest of Middle East and Africa.
AstraZeneca; Teva Pharmaceutical Industries Ltd; Boehringer Ingelheim International GmbH; GlaxoSmithKline plc.; Merck & Co., Inc.; Koninklijke Philips N.V.; Sanofi; Pfizer Inc. (Arena Pharmaceutical GmbH); Novartis AG; and Abbott are among the leading companies operating in the Middle East and Africa asthma drugs market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Asthma Drugs Market – By Medication
1.3.2 Middle East and Africa Asthma Drugs Market – By Route of Administration
1.3.3 Middle East and Africa Asthma Drugs Market – By Distribution Channel
1.3.4 Middle East and Africa Asthma Drugs Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Asthma Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Expert Opinion
5. Asthma Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Environmental Implications & Genetic Implications of Air Pollution
5.1.2 More Vulnerability in Specific Ethnic Groups
5.1.3 Growing Exposure to Coarse Particulate Matters
5.1.4 Growing Prevalence of Physiological Disorders Harboring Asthma
5.2 Market Restraints
5.2.1 Unmet Medical Needs
5.3 Market Opportunities
5.3.1 Opportunities with Commercialization of Biologics
5.4 Future Trends
5.4.1 Increasing Research Activities and Product Innovations
5.5 Impact Analysis
6. Asthma Drugs Market – Middle East and Africa Analysis
6.1 Middle East and Africa Asthma Drugs Market Revenue Forecast and Analysis
7. Asthma Drugs Market Analysis – by Medication
7.1 Overview
7.2 Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
7.3 Quick Relief Medications
7.3.1 Overview
7.3.2 Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Long-term Control Medications
7.4.1 Overview
7.4.2 Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
8. Asthma Drugs Market Analysis – By Route of Administration
8.1 Overview
8.2 Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)
8.3 Inhaled
8.3.1 Overview
8.3.2 Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.4 Prefilled Syringe/Vials
8.4.1 Overview
8.4.2 Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.5 Others (Oral, Nasal, Ophthalmic Etc.)
8.5.1 Overview
8.5.2 Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9. Asthma Drugs Market Analysis – By Distribution Channel
9.1 Overview
9.2 Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.5 Retail Pharmacies and Drugstores
9.5.1 Overview
9.5.2 Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
10. Asthma Drugs Market – Middle East and Africa Analysis
10.1 Middle East & Africa: Asthma Drugs Market
10.1.1 Middle East & Africa: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
10.1.2 Middle East & Africa: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.1.3 Middle East & Africa: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.1.4 Middle East & Africa: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.1.5 Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)
10.1.5.1 UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.1.5.1.3 UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
10.1.5.1.3.1 UAE: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
10.1.5.1.3.2 UAE: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
10.1.5.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.1.5.2.3 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
10.1.5.2.3.1 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
10.1.5.2.3.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
10.1.5.3 South Africa: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 South Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.1.5.3.3 South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
10.1.5.3.3.1 South Africa: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
10.1.5.3.3.2 South Africa: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
10.1.5.4 Rest of Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.4.1 Rest of Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.5.4.2 Rest of Middle East & Africa: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.1.5.4.3 Rest of Middle East & Africa: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.1.5.4.4 Rest of Middle East & Africa: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
11. Asthma Drugs Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 AstraZeneca
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GlaxoSmithKline plc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck & Co., Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips N.V.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sanofi
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Pfizer Inc. (Arena Pharmaceutical GmbH)
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novartis AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Abbott
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Odds Ratio (OR) For Mental Disorders among Adults with Asthma Vs Without Asthma
Table 2. Asthma Death Rates for Select Countries, 2018
Table 3. Common SABAs
Table 4. Commonly inhaled corticosteroids
Table 5. Middle East & Africa Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 6. Middle East & Africa Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 7. Middle East & Africa Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
Table 9. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 10. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 11. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
Table 12. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 13. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 14. South Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
Table 15. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 16. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 17. Rest of Middle East & Africa Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East & Africa Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East & Africa Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments in the Asthma Drugs Market
Table 21. Inorganic Developments in the Asthma Drugs Market
Table 22. Glossary of Terms, Asthma Drugs Market
LIST OF FIGURES
Figure 1. Asthma Drugs Market Segmentation
Figure 2. Asthma Drugs Market, By Country
Figure 3. Middle East and Africa Asthma Drugs Market Overview
Figure 4. The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market
Figure 5. Middle East and Africa Asthma Drugs Market- Leading Country Markets (US$ Million)
Figure 6. Middle East & Africa PEST Analysis
Figure 7. Expert Opinion
Figure 8. Impact of Low Mood/Anxiety on Asthma
Figure 9. Asthma Drugs Market Impact Analysis of Drivers and Restraints
Figure 10. Middle East and Africa Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028
Figure 11. Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
Figure 12. Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)
Figure 15. Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 16. Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 17. Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 18. Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)
Figure 19. Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 20. Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 21. Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 22. Middle East & Africa: Asthma Drugs Market, by Key Country – Revenue (2020) (USD Million)
Figure 23. Middle East & Africa Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 24. Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)
Figure 25. UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 26. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Rest of Middle East & Africa Asthma Drugs Products Market Revenue and Forecasts to 2028 (US$ Mn)
- AstraZeneca
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- GlaxoSmithKline plc.
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Koninklijke Philips N.V.
- Sanofi
- Pfizer Inc. (Arena Pharmaceutical GmbH)
- Novartis AG
- Abbott
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa asthma drugs market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa asthma drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.